Masimo (NASDAQ:MASI) Hits New 12-Month High – Time to Buy?

Masimo Corporation (NASDAQ:MASI)’s stock price hit a new 52-week high during trading on Wednesday . The company traded as high as $180.02 and last traded at $178.6250, with a volume of 2581 shares. The stock had previously closed at $178.55.

Wall Street Analysts Forecast Growth

MASI has been the topic of a number of recent research reports. Raymond James Financial lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Wolfe Research cut Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Wells Fargo & Company upgraded Masimo to a “hold” rating in a report on Wednesday, March 18th. BTIG Research cut Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Finally, Stifel Nicolaus set a $180.00 target price on Masimo in a report on Tuesday, February 17th. Nine investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, Masimo presently has a consensus rating of “Hold” and a consensus price target of $180.40.

Masimo Trading Down 0.0%

The business has a 50 day moving average of $177.72 and a two-hundred day moving average of $155.71. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68. The firm has a market capitalization of $9.34 billion, a price-to-earnings ratio of -16.92, a P/E/G ratio of 1.81 and a beta of 1.13.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Jupiter Asset Management Ltd. purchased a new position in shares of Masimo during the third quarter valued at approximately $12,491,000. American Century Companies Inc. boosted its position in shares of Masimo by 10.6% during the third quarter. American Century Companies Inc. now owns 168,341 shares of the medical equipment provider’s stock valued at $24,839,000 after buying an additional 16,113 shares during the last quarter. ING Groep NV bought a new stake in Masimo in the 3rd quarter worth about $3,069,000. Citigroup Inc. grew its position in Masimo by 133.5% in the 3rd quarter. Citigroup Inc. now owns 116,672 shares of the medical equipment provider’s stock worth $17,215,000 after purchasing an additional 66,710 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its position in shares of Masimo by 483.7% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 11,371 shares of the medical equipment provider’s stock valued at $1,561,000 after purchasing an additional 9,423 shares during the last quarter. 85.96% of the stock is owned by institutional investors.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.